Press Releases

Nov 19, 2020 6:30am EST

Lexaria Bioscience Sells Non-Pharmaceutical THC-Related Assets for CDN$3.85M

Nov 05, 2020 6:45am EST

Lexaria Bioscience Advances 2021 Strategic Initiatives

Oct 26, 2020 2:30pm EDT

Lexaria Bioscience Extends Warrant Term

Oct 22, 2020 6:15am EDT

Lexaria Proprietary DehydraTECH-Enabled CBD Powders Business Growing Faster than Expected

Oct 21, 2020 6:15am EDT

Lexaria Bioscience Granted First European Patent for DehydraTECH Technology

Oct 09, 2020 4:10pm EDT

Lexaria Provides Update on Ongoing Business Relationship with Altria Ventures

Sep 29, 2020 6:25am EDT

Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTECH Technology in Delivering Antiviral Drugs

Sep 23, 2020 6:15am EDT

Lexaria Receives Orders for 4.4 Million Servings of DehydraTECH-Enabled CBD Powders

Sep 22, 2020 6:15am EDT

Lexaria Bioscience Continues to Grow its Patent Portfolio

Sep 16, 2020 6:25am EDT

Lexaria Bioscience Supports Corporate Growth Initiatives by its Licensee, Cannadips CBD by the Boldt Runners Corporation